Nasal colonization of Staphylococcus aureus and the risk of surgical site infection after spine surgery: a meta-analysis

Nasal colonization of Staphylococcus aureus and the risk of surgical site infection after spine surgery: a meta-analysis

Journal Pre-proof Nasal colonization of Staphylococcus aureus and the risk of surgical site infection after spine surgery: a meta-analysis Jintang Ni...

1MB Sizes 0 Downloads 26 Views

Journal Pre-proof

Nasal colonization of Staphylococcus aureus and the risk of surgical site infection after spine surgery: a meta-analysis Jintang Ning , Jimei Wang , Songzhen Zhang , Xiaojuan Sha PII: DOI: Reference:

S1529-9430(19)31055-1 https://doi.org/10.1016/j.spinee.2019.10.009 SPINEE 58043

To appear in:

The Spine Journal

Received date: Revised date: Accepted date:

13 August 2019 18 October 2019 18 October 2019

Please cite this article as: Jintang Ning , Jimei Wang , Songzhen Zhang , Xiaojuan Sha , Nasal colonization of Staphylococcus aureus and the risk of surgical site infection after spine surgery: a metaanalysis, The Spine Journal (2019), doi: https://doi.org/10.1016/j.spinee.2019.10.009

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2019 Published by Elsevier Inc.

Nasal colonization of Staphylococcus aureus and the risk of surgical site infection after spine surgery: a meta-analysis

Running title: Meta-analysis on nasal colonization and SSI

Authors: Jintang Ning 1*, Jimei Wang 1*, Songzhen Zhang 1, and Xiaojuan Sha 2 *, these authors contributed equally to this work

Affiliations: 1, Department of Pharmacy, Dongying People’s Hospital, Dongying 257091, China 2, Department of Public Health, Qingdao Sanatorium, Qingdao 266000, China

Corresponding author: Dr. Jimei Wang, Department of Pharmacy, Dongying People’s Hospital, No. 317 Nanyi Road, Dongying 257091, China; Telephone: +86-0546-8331577; Fax: +86-0546-8331577; Email: [email protected]

Funding Disclosure(s) Statement The authors received no funding for this study.

1

Nasal colonization of Staphylococcus aureus and the risk of surgical site infection after spine surgery: a meta-analysis

Running title: Meta-analysis on nasal colonization and SSI

2

1

Abstract

2 3

Background context: Nasal colonization of Staphylococcus aureus (SA) may increase the risk

4

of surgical site infection (SSI) after spine surgeries, although the results of previous studies

5

were inconsistent.

6

Purpose: To evaluate the influences of nasal colonization of SA, methicillin-susceptible SA

7

(MSSA), and methicillin-resistant SA (MRSA) on the incidence of SSI after spine surgery.

8

Study design/setting: systematic review and meta-analysis.

9

Patient sample: Seven studies including 10,650 patients who underwent nasal swab

10

examination before spine surgeries were included, and 221 patients had nasal colonization of

11

MRSA at baseline.

12

Outcome measures: Association between baseline nasal colonization of SA, MRSA and SSI

13

after spine surgery.

14

Methods: Relevant follow-up studies were identified through systematic searches of the

15

PubMed, Embase, and Cochrane Library databases. A random effects model was applied to

16

pool the results. Subgroup analyses were performed according to whether MRSA

17

decolonization was applied.

18

Results: During follow-up, a total of 244 SSI events occurred, including 57 MRSA-SSI

19

events. Pooled results showed that nasal SA (risk ratio [RR]=0.75, p=0.22) or MSSA

20

colonization (RR=0.60, p=0.22) did not significantly affect the risk of overall SSI after

21

surgeries. However, nasal MRSA colonization was associated with significantly increased

3

1

risks of overall SSI and MRSA-SSI (RR=2.52 and 6.21 respectively, both p<0.001).

2

Interestingly, the associations between nasal MRSA colonization and increased risks of

3

overall and MRSA-SSI remained significant in studies without MRSA decolonization, but

4

became insignificant in studies with MRSA decolonization.

5

Conclusions: Nasal MRSA colonization may be associated with increased risks of overall SSI

6

and MRSA-SSI after spine surgeries, and nasal MRSA decolonization may be associated with

7

a reduction of SSI in these patients.

8 9 10

Keywords: Staphylococcus aureus; Nasal colonization; Spine surgery; Surgical site infection; Meta-analysis

11 12 13 14 15

4

1

Introduction

2 3

With continuous improvements of surgical instrumentation and techniques, many spinal

4

procedures that were unable to be performed previously have become feasible and increasing

5

numbers of spine surgeries are being performed [1, 2]. However, the complexity of the spine

6

surgical procedures has also resulted in a high incidence of surgical site infection (SSI) [3].

7

According to previous reports, the risk of SSI associated with spine surgeries is higher than

8

that with general orthopedic surgeries [4]. In a report from the National Nosocomial

9

Infections Surveillance System, the incidence of SSI among patients who have undergone

10

spinal fusion surgery ranged between 2.4% and 8.5% [5]. Because the incidence of SSI after

11

spine surgery contributes to increased patient mortality and medical costs [6, 7], early

12

identification of patients at high risk for the development of SSI after spine surgery is of

13

clinical significance.

14 15

The pathogenesis of SSI is complicated which may involve many clinical factors [8]. Recent

16

evidence from studies in patients treated with cardiac or orthopedic surgeries indicated that

17

nasal colonization of Staphylococcus aureus (SA), particularly of the methicillin-resistant SA

18

(MRSA), may increase the risk of SSI after surgeries [9, 10]. However, pilot studies

19

investigating the role of nasal colonization of SA in patients who have undergone spine

20

surgeries have produced inconsistent results [11-17]. Although some early studies confirmed

21

the potential predictive role of nasal MRSA colonization for SSI after spine surgeries [11, 12,

5

1

15], others did not support that nasal MRSA colonization is associated with the risk of SSI in

2

these patients [13, 14, 16, 17]. Because the numbers of patients included in these pilot studies

3

are generally small, especially for the groups with nasal MRSA colonization, it is possible

4

that the limited study scales may be statistically inadequate to provide a significant result.

5

Therefore, in the present study, we aimed to pool the results of the previous studies in a

6

meta-analysis to systematically evaluate the influences of nasal colonization of SA,

7

methicillin-susceptible SA (MSSA), and MRSA on the incidence of SSI after spine surgeries.

8 9 10

Methods

11 12

This study was performed in accordance with the MOOSE (Meta-analysis of Observational

13

Studies in Epidemiology) [18] and Cochrane’s Handbook [19] guidelines.

14 15

Database search

16

We searched the PubMed, Embase, and Cochrane Library databases for relevant studies,

17

using combinations of the following terms: (1) "staphylococcus"; (2) "nasal" OR "nose"; (3)

18

"spine" OR "spinal" OR "vertebral" OR "vertebrate"; and (4) "surgery" OR "surgical" OR

19

"procedure" OR "operation" OR" operative". We limited the search to human studies

20

published in English. A manual analysis of the reference lists of original and review articles

21

was performed as a supplementation. The final search was performed on May 05, 2019.

6

1 2

Inclusion and exclusion criteria

3

The aim of the study was to answer the following four questions in patients who underwent

4

spine surgeries: (1) Is the incidence of overall SSI higher among SA-colonized patients than

5

among noncolonized patients? (2) Is the incidence of overall SSI higher among

6

MSSA-colonized patients higher than among noncolonized patients? (3) Is the incidence of

7

overall SSI higher among MRSA-colonized patients than among noncolonized patients? and

8

(4) Is the incidence of MRSA-SSI higher among MRSA-colonized patients than among

9

noncolonized patients? Accordingly, articles were included if they met the following criteria:

10

(1) full-length article in English; (2) reported data from longitudinal follow-up; (3) included

11

patients scheduled for spine surgery for non-infectious diseases; (4) reported results of nasal

12

swab performed before surgery to screen for colonization of SA, MSSA, or MRSA; and (5)

13

documented the incidence of total SSI events and/or MRSA-SSI events according to the

14

status of nasal SA colonization. The SSI events were defined based on the 2017 Centers for

15

Disease Control criteria for wound surveillance as previously described [20]. Reviews, letters,

16

editorials, and studies without longitudinal follow-up were excluded.

17 18

Data extraction and quality evaluation

19

Database searching, data extraction, and quality assessment were performed by two authors

20

independently, and discrepancies were resolved by consultation with the corresponding

21

author. The data extracted included: (1) first author, location, and study design characteristics;

7

1

(2) procedure characteristics and number, mean age, and gender of patients; (3) methods for

2

screening of nasal SA colonization, proportions of patients with nasal SA and MRSA

3

colonization before surgeries, and strategies for decolonization for nasal MRSA carriers; (4)

4

follow-up durations and SSI outcomes reported; and (5) total numbers of SA-, MSSA-, and

5

MRSA-colonized patients and noncolonized patients according to the results of nasal swab

6

examination and the number of patients with overall SSI and MRSA-SSI in each group after

7

spine surgeries. Study quality evaluation was performed with the Newcastle-Ottawa Scale

8

(NOS) [21], which ranks studies from 1 to 9 stars and judges each study with regard to three

9

aspects: selection of study groups; comparability of groups; and ascertainment of the outcome

10

of interest.

11 12

Statistical analyses

13

We used risk ratios (RRs) with 95% confidence interval (CIs) to estimate the risk of SSI

14

events in patients with various nasal colonization statuses after spine surgeries [19]. The

15

Cochrane’s Q test and I2 test were performed to evaluate the heterogeneity among studies

16

[22]. An I2 > 50% indicated significant heterogeneity. A random effects model was applied to

17

pool the data, because this model incorporates the potential heterogeneity to generate a more

18

generalized result [19]. Sensitivity analyses in which individual studies were removed one at

19

a time were performed to evaluate the stability of the results [23]. A predefined subgroup

20

analysis was performed to evaluate whether nasal decolonization affects the association

21

between nasal MRSA colonization and SSI after spine surgery. Potential publication bias was

8

1

assessed by funnel plots with the Egger regression asymmetry test [24]. RevMan (Version 5.1;

2

Cochrane Collaboration, Oxford, UK) software was used for the statistical analyses.

3 4 5

Results

6 7

Results of literature search

8

The process of the literature search is shown in Figure 1. Overall, 293 studies were obtained

9

after the initial literature search, and 277 were excluded based on the screening of titles and

10

abstracts primarily because of irrelevance to the aim of the meta-analysis. Finally, seven

11

follow-up studies [11-17] were included.

12 13

Study characteristics and quality evaluation

14

The characteristics of the included studies are presented in Table 1. Overall, 10,650 patients

15

who underwent nasal swab examination before spine surgeries were included, and 221

16

patients had nasal colonization of MRSA at baseline. During follow-up, a total of 244 SSI

17

events occurred, including 57 MRSA-SSI events. The studies were published between 2014

18

and 2018 and performed in the United States [11-13, 17], Japan [14, 15], and France [16].

19

Five were retrospective studies [11-14, 17], whereas two were prospectively designed [15,

20

16]. All of the studies included patients who underwent spine surgeries for non-infectious

21

diseases, with nasal swab performed before surgery to identify nasal SA colonization. The

9

1

timing of nasal screening varied from one week to 12 months before surgery. The times of

2

nasal culture required to confirm nasal colonization were not reported in all of the included

3

studies. At baseline, 18.8%–35.6% of the patients were colonized with SA, and 1.1%–5.9%

4

of the patients were colonized with MRSA. For patients with nasal colonization with MRSA,

5

decolonization with topical mupirocin and/or intravenous (i.v.) vancomycin was applied in

6

four studies [12, 13, 15, 16], while decolonization was not applied in the other three studies

7

[11, 14, 17]. The patients were followed for up to 1 year. The outcomes of overall SSI events

8

were reported in all of the included studies, while five studies reported MRSA-SSI events [11,

9

12, 15-17]. The qualities of the included studies were moderate, with NOS scores varying

10

between six and seven points.

11 12

Nasal SA or MSSA colonization and the risk of SSI after spine surgery

13

The pooled results from four studies [11-13, 16] showed that nasal SA colonization was not

14

likely to affect the risk of overall SSI in patients after spine surgery (RR=0.75, 95% CI:

15

0.47–1.19; p=0.22; Figure 2A). No significant heterogeneity was detected (p for Cochrane’s

16

Q test =0.37, I2=5%). Sensitivity analyses with one study excluded at a time produced the

17

same results (RR=0.60–0.82, all p>0.05). Similarly, the pooled results from four studies

18

[11-13, 16] showed that nasal MSSA colonization was also unlikely to affect the risk of

19

overall SSI in patients after spine surgery (RR=0.66, 95% CI: 0.34–1.29; p=0.22; Figure 2B).

20

No significant heterogeneity was detected (p for Cochrane’s Q test =0.32, I2=31%).

21

Sensitivity analyses with one study excluded at a time returned consistent results (RR: 0.49–

10

1

0.77, all p>0.05).

2 3

Nasal MRSA colonization and the risk of overall SSI after spine surgery

4

The pooled results from seven studies [11-17] showed that nasal MRSA colonization may be

5

associated with a significantly increased risk of overall SSI in patients after spine surgery

6

(RR=2.52, 95% CI: 1.36–4.67; p=0.003; Figure 3A). No significant heterogeneity was

7

detected (p for Cochrane’s Q test =0.30, I2=17%). Sensitivity analyses with one study

8

excluded produced the same results (RR: 2.03–3.15, all p<0.05). Subgroup analyses showed

9

that nasal MRSA colonization may also be associated with an increased risk of overall SSI in

10

studies in which decolonization of MRSA was not applied (RR=3.04, 95% CI: 1.22–7.62;

11

p=0.02), but the association became insignificant in the analysis of studies in which

12

decolonization of MRSA was applied (RR=1.98, 95% CI: 0.75–5.02; p=0.15). These results

13

suggest that decolonization of MRSA may be associated with a reduction in the overall risk

14

of SSI in patients with nasal MRSA colonization after spine surgeries.

15 16

Nasal MRSA colonization and the risk of MRSA-SSI after spine surgery

17

The pooled results from five studies [11, 12, 15-17] showed that nasal MRSA colonization

18

may be associated with an increased risk of MRSA-SSI in patients after spine surgery

19

(RR=6.21, 95% CI: 2.37–16.25; p<0.001; Figure 3B). No significant heterogeneity was

20

detected (p for Cochrane’s Q test =0.56, I2=0%). Sensitivity analyses with one study excluded

21

at a time returned consistent results (RR: 4.47–8.27, all p<0.05). Subgroup analyses showed

11

1

that nasal MRSA colonization may be associated with an increased risk of MRSA-SSI in

2

studies in which decolonization of MRSA was not applied (RR=15.02, 95% CI: 3.69–61.19;

3

p<0.001), but the association became insignificant in the analysis of studies in which

4

decolonization of MRSA was applied (RR=2.85, 95% CI: 0.76–10.66; p=0.12). These results

5

suggest that decolonization of MRSA may be associated with a reduced risk of MRSA-SSI in

6

patients with nasal MRSA colonization after spine surgery.

7 8

Publication bias

9

Funnel plots for the associations between nasal SA, MSSA, and MRSA colonization and

10

overall SSI risk as well as the association between nasal MRSA colonization and MRSA-SSI

11

risk are shown in Figure 4A-D. The funnel plots were symmetric on visual inspection.

12

Egger’s regression tests were not performed due to the limited number of studies included.

13 14

Discussion

15

In this meta-analysis of pooled results from seven follow-up studies, we found that nasal

16

colonization of SA or MSSA was unlikely to be associated with a significantly increased risk

17

of SSI after spine surgery. However, nasal colonization of MRSA may be associated with

18

increased risks for overall SSI and MRSA-SSI after spine surgery. Interestingly, subgroup

19

analyses showed that the association between nasal MRSA colonization and the increased

20

risk of SSI seemed to be mainly driven by studies in which nasal MRSA decolonization was

21

not applied. In the subgroup analysis of studies in which nasal MRSA decolonization was

12

1

applied, the associations between nasal MRSA colonization and increased risks of overall SSI

2

and MRSA-SSI became insignificant. These results suggest that nasal MRSA colonization

3

may be associated with an increased risk of overall SSI and MRSA-SSI after spine surgery,

4

while nasal MRSA decolonization may be associated with a reduction in the risk of SSI in

5

these patients.

6 7

The association between nasal carriage of SA and SSI has been suggested by studies of

8

patients receiving orthopedic surgeries. In an early meta-analysis of six studies, Levy et al

9

demonstrated that nasal carriage of SA is a major risk factor for SSI after general orthopedic

10

surgeries (pooled odds ratio [OR]=5.92, p=0.03). However, these results were based on direct

11

pooling of the ORs from individual studies, and considerable heterogeneity was detected

12

(I2=90%). As mentioned by the authors, the considerable heterogeneity among the included

13

studies was reflective of the different study characteristics and methodology of the included

14

studies, which makes the interpretation of the results difficult [25]. Also, the authors were

15

unable to determine which strains of SA (MSSA or MRSA) contributed to the potential

16

association between nasal colonization of SA and SSI after orthopedic surgeries. Moreover,

17

the previous hypothesis that nasal SA colonization is the major acquisition pathway for SSI

18

after orthopedic surgery has been challenged by the inconsistent results of some studies.

19

Berthelot et al. investigated a total of 3,908 consecutive patients undergoing orthopedic

20

surgery [26]. For 22 patients with SSI related to SA, only nine were nasal SA carriers before

21

surgery [26]. Moreover, among the nine nasal SA carriers who developed SSI, three had

13

1

different pairs of SA strains on nasal swabs and at the infection site, suggesting that the

2

association between nasal SA colonization and SA-related SSI may not be as close as

3

previously considered [26]. In our study, by pooling the results of all available follow-up

4

studies of patients who received spine surgeries, nasal colonization of SA or MSSA was

5

unlikely to be associated with increased risks of SSI. These findings also support the

6

uncertainty of the association between SA (primarily MSSA) and the affected SSI risk after

7

spine surgeries. Another potential mechanism, from our perspective, perhaps is that the

8

intensive administration of perioperative antibiotics for patients scheduled to undergo spine

9

surgery may block the potential acquisition of MSSA from endogenous colonization to the

10

surgical sites.

11 12

Another finding of our meta-analysis is that nasal colonization of MRSA seemed to be

13

associated with increased risks of overall SSI and MRSA-SSI after spine surgery. These

14

results may indicate the importance of screening for nasal colonization of MRSA, rather than

15

MSSA, for the identification of patients at higher risk for development of SSI. Further

16

subgroup analyses showed that the association between nasal MRSA colonization and an

17

increased risk of SSI was mainly driven by studies in which nasal MRSA decolonization was

18

not applied. From the subgroup analysis of studies in which nasal MRSA decolonization was

19

applied, the associations between nasal MRSA colonization and increased risk of overall and

20

MRSA-SSI became insignificant. These results suggest that nasal MRSA colonization may be

21

a risk factor for the development of SSI after spine surgery, and effective decolonization of

14

1

nasal MRSA may help to prevent SSI. This is consistent with the findings of a previous

2

meta-analysis of patients treated with cardiac or general orthopedic procedures. The previous

3

meta-analysis included 39 studies of patients who underwent cardiac or total joint

4

replacement procedures and demonstrated that application of glycopeptide prophylaxis with

5

or without nasal decolonization significantly reduced the risk of MRSA-SSI [27]. In another

6

recently published meta-analysis of patients who received total knee and hip arthroplasty,

7

Sadigursky et al. found that the use of a prophylaxis protocol for decolonization of MRSA

8

significantly reduced the incidence of SSI by 39% in these patients. These findings, together

9

with ours, demonstrate that nasal colonization of MRSA may be a risk factor of SSI after

10

surgery, and screening and decolonization of nasal MRSA may be effective at reducing the

11

incidence of SSI after spine surgery.

12 13

It has to be mentioned that the pathogenesis of SSI after spine surgeries is multifactorial [28].

14

Many clinical factors, including patient characteristics (e.g., obesity, diabetes, and smoking),

15

a longer operative time, transfusion during the operation, and other factors have been

16

suggested to be important risk factors for the incidence of SSI after spine surgeries [8, 29].

17

Due to the limited number of cases with SSI in each study and small number of available

18

studies in our meta-analysis, our analysis for the association between nasal MRSA

19

colonization and SSI after surgery was based on univariate findings rather than multivariable

20

adjusted findings. The potential imbalance of these clinical factors related to SSI may

21

confound our finding of the association between nasal MRSA colonization and incidence of

15

1

SSI after spine surgeries. Our results should be confirmed in cohort studies with larger

2

sample sizes that incorporate adequate adjustment of multiple factors that may influence the

3

SSI, such as the prevalence of diabetes between groups, differences in the immune status of

4

patients, and differences in surgical times and procedure characteristics.

5 6

Our study has limitations. First, the number of included studies was small, which prevented

7

us from evaluating the potential influences of patient (e.g., smoking status, with or without

8

diabetes, and hypertension) or procedure characteristics (different types of spine surgeries) on

9

the association between nasal SA colonization and SSI events after spine surgeries. Second,

10

we only included studies published in English, which may lead to additional bias by

11

potentially missing of studies published in other languages. Third, as a meta-analysis of

12

observational studies, a causative association between nasal MRSA colonization and the

13

increased risk of SSI after spine surgeries could not be retrieved based on our results. Fourth,

14

also due to the nature of a meta-analysis of observational studies, we could not exclude the

15

possibility that potential clinical factors for SSI may confound our findings. Moreover,

16

although the potential efficacy of nasal MRSA decolonization for the prevention of SSI after

17

spine surgery should be optimally investigated in randomized controlled trials, due to the

18

ethical reasons, these clinical trials cannot be performed. Finally, the optimal regimens for

19

nasal MRSA decolonization should be evaluated in future studies.

20 21

In conclusion, nasal MRSA colonization may be associated with increased risks of overall

16

1

SSI and MRSA-SSI after spine surgeries, while nasal MRSA decolonization may be

2

associated with a reduction in the risk of SSI in these patients. Further studies are needed to

3

validate our findings and determine whether the association between nasal MRSA

4

colonization and SSI after spine surgery is independent of the characteristics of patients and

5

surgical procedures. Moreover, the optimal regimens for nasal MRSA decolonization remain

6

to be determined.

7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

References 1.

Rezai AR. The evolution of technology and neurosurgery: Presidential address of the 2013 CNS Annual

Meeting. Neurosurgery. 2014;61 Suppl 1:66-8. 2.

Kamat AS, Parker A. The evolution of neurosurgery: how has our practice changed? Br J Neurosurg.

2013;27(6):747-51. 3.

Epstein NE. Preoperative measures to prevent/minimize risk of surgical site infection in spinal surgery.

Surg Neurol Int. 2018;9:251. 4.

Pull ter Gunne AF, Hosman AJ, Cohen DB, et al. A methodological systematic review on surgical site

infections following spinal surgery: part 1: risk factors. Spine (Phila Pa 1976). 2012;37(24):2017-33. 5.

Gaynes RP, Culver DH, Horan TC, Edwards JR, Richards C, Tolson JS. Surgical site infection (SSI) rates in the

United States, 1992-1998: the National Nosocomial Infections Surveillance System basic SSI risk index. Clin Infect Dis. 2001;33 Suppl 2:S69-77. 6.

Atkinson RA, Jones A, Ousey K, Stephenson J. Management and cost of surgical site infection in patients

undergoing surgery for spinal metastasis. J Hosp Infect. 2017;95(2):148-53. 7.

Yin D, Liu B, Chang Y, Gu H, Zheng X. Management of late-onset deep surgical site infection after

instrumented spinal surgery. BMC Surg. 2018;18(1):121. 8.

Peng XQ, Sun CG, Fei ZG, Zhou QJ. Risk Factors for Surgical Site Infection After Spinal Surgery: A Systematic

Review and Meta-Analysis Based on Twenty-Seven Studies. World Neurosurg. 2019;123:e318-e29. 9.

Patel H, Khoury H, Girgenti D, Welner S, Yu H. Burden of Surgical Site Infections Associated with Select

Spine Operations and Involvement of Staphylococcus aureus. Surg Infect (Larchmt). 2017;18(4):461-73. 10. Humphreys H, Becker K, Dohmen PM, et al. Staphylococcus aureus and surgical site infections: benefits of screening and decolonization before surgery. J Hosp Infect. 2016;94(3):295-304. 11. Thakkar V, Ghobrial GM, Maulucci CM, et al. Nasal MRSA colonization: impact on surgical site infection following spine surgery. Clin Neurol Neurosurg. 2014;125:94-7. 12. Luhmann SJ, Smith JC. Preoperative MRSA Screening in Pediatric Spine Surgery: A Helpful Tool or a Waste

17

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42

of Time and Money? Spine Deform. 2016;4(4):272-6. 13. Ramos N, Stachel A, Phillips M, Vigdorchik J, Slover J, Bosco JA. Prior Staphylococcus Aureus Nasal Colonization: A Risk Factor for Surgical Site Infections Following Decolonization. J Am Acad Orthop Surg. 2016;24(12):880-5. 14. Kawabata A, Sakai K, Sato H, et al. Methicillin-Resistant Staphylococcus aureus Nasal Swab and Suction Drain Tip Cultures in 4573 Spinal Surgeries: Efficacy in Management of Surgical Site Infections. Spine (Phila Pa 1976). 2018;43(7):E430-E5. 15. Kobayashi K, Ando K, Ito K, et al. Prediction of surgical site infection in spine surgery from tests of nasal MRSA colonization and drain tip culture. Eur J Orthop Surg Traumatol. 2018;28(6):1053-7. 16. Mallet C, Caseris M, Doit C, et al. Does Staphylococcus aureus nasal decontamination affect the rate of early surgical site infection in adolescent idiopathic scoliosis surgery? Eur Spine J. 2018;27(10):2543-9. 17. Nielsen E, Andras LM, Harris LR, Skaggs DL. Methicillin-resistant Staphylococcus aureus Swab Results Did Not Change Treatment or Outcome in Pediatric Spinal Fusion Patients. J Am Acad Orthop Surg. 2018;26(17):617-23. 18. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008-12. 19. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration. 2011;www.cochranehandbook.org. 20. Berrios-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg. 2017;152(8):784-91. 21. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised

studies

in

meta-analyses.

2010;http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. 22. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-58. 23. Patsopoulos NA, Evangelou E, Ioannidis JP. Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol. 2008;37(5):1148-57. 24. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-34. 25. Levy PY, Ollivier M, Drancourt M, Raoult D, Argenson JN. Relation between nasal carriage of Staphylococcus aureus and surgical site infection in orthopedic surgery: the role of nasal contamination. A systematic literature review and meta-analysis. Orthop Traumatol Surg Res. 2013;99(6):645-51. 26. Berthelot P, Grattard F, Cazorla C, et al. Is nasal carriage of Staphylococcus aureus the main acquisition pathway for surgical-site infection in orthopaedic surgery? Eur J Clin Microbiol Infect Dis. 2010;29(4):373-82. 27. Schweizer M, Perencevich E, McDanel J, et al. Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review and meta-analysis. BMJ. 2013;346:f2743. 28. Boody B, Vaccaro AR. Point-of-View: Risk Factors for Surgical Site Infection After Posterior Lumbar Spinal Surgery. Spine (Phila Pa 1976). 2018;43(10):738. 29. Fei Q, Li J, Lin J, et al. Risk Factors for Surgical Site Infection After Spinal Surgery: A Meta-Analysis. World Neurosurg. 2016;95:507-15.

18

Figure legends

Figure 1 Diagram of study selection.

19

Figure 2 Forest plots for the meta-analysis of associations of nasal colonization of (A) SA and (B) MSSA with overall SSI risk after spine surgery.

20

Figure 3 Forest plots for the meta-analysis of associations of nasal colonization of MRSA with (A) overall SSI and (B) MRSA-SSI risk after spine surgery.

21

Figure 4 Funnel plots for the associations of nasal colonization of (A) SA, (B) MSSA, and (C) MRSA with the risk of SSI after spine surgery, and for the association of nasal colonization of (D) MRSA with the risk of MRSA-SSI after spine surgery.

22

Table 1 Characteristics of the included studies. Study

Design

Country

Patients and

Number

procedures

of patients

Mean age years

Thakkar 2014

RC

USA

Male

Screening method

%

Patients

Nasal

underwent spine

swab,

surgeries for

519

59

48

within 30

arthrodesis and

days before

decompression

surgery

Nasal

Nasal

Decolonization

SA

MRSA

methods for

positive

positive

MRSA

%

%

26.0

4.8

Follow-up duration

SSI outcomes reported

NOS score

months MRSA-SSI NA

12

and overall

6

SSI

Patients Ramos 2016

underwent spine RC

USA

surgeries for

Nasal swab 3556

51

52

primary spinal

before

Topical 18.8

2.7

admission

mupirocin and

12

Overall SSI

7

i.v. vancomycin

fusion Pediatric Luhmann 2016

RC

USA

patients who had spine surgery

Nasal swab 339

13

NA

1-4 weeks before

22.1

5.9

Topical mupirocin

MRSA-SSI 12

Kobayashi 2018

PC

Japan

underwent instrumental

Nasal swab 132

45

50

2018

PC

France

Patients underwent

35.6

3.8

admission

spine surgery Mallet

before

331

16

17

Nasal swab for twice

23

22.7

3

Topical mupirocin Topical mupirocin and

6

SSI

surgery Patients

and overall

MRSA-SSI 12

and overall

6

SSI 11

MRSA-SSI and overall

7

adolescent

within 12

idiopathic

months

scoliosis surgery

i.v. vancomycin

SSI

before surgery

Patients Nielsen 2018

RC

USA

underwent posterior spinal

Nasal swab 1200

14

36

fusion

2018

RC

Japan

underwent elective spine surgery

MRSA-SSI NR

2.8

NA

12

surgery

Patients Kawabata

before

and overall

6

SSI

Nasal swab 4573

61

60

before

NR

1.1

NA

12

Overall SSI

7

surgery

SA, Staphylococcus aureus; MRSA, methicillin-resistant Staphylococcus aureus; SSI, surgical site infection; NOS, Newcastle-Ottawa Scale; RC, retrospective cohort; PC, prospective cohort; NR, not reported; NA, not applied; i.v., intravenous

24